Braftovi | Encorafenib (download only)

Regular price $0.00

A download link will be emailed after check out.

Braftovi (encorafenib) in combination with Erbitux (cetuximab) is a treatment option for patients with BRAF V600E-variant metastatic bowel cancer (mCRC) who have received prior systemic therapy.